Details of the Drug Reposition

General Information of This Drug (ID: DMYGJQO)

Drug Name
Ponatinib   DMYGJQO
Synonyms Iclusig (TN)
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Thyroid tumor DISLVKMD N.A. Approved [1]
Chronic myelogenous leukaemia DIS0301E 2A20.0 Approved [1]
------------------------------------------------------------------------------------
1 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Acute lymphocytic leukaemia DISPX75S 2B33.3 Discontinued in Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Ponatinib FDA Label
2 An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain